上海赛默罗生物科技有限公司 Shanghai SIMR Biotech Co.Ltd
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Key Milestone: The first patient successfully dosed with the candidate drug SR419 for peripheral neuropathic pain 2020-09-21 10:35
1